Marcia Dawson, Ph.D.

The Burnham Institute for Medical Research
email: none

Grants

Novel Retinoids with Enhanced Anti-Breast Tumor Efficacy 2002 (Cycle VIII)
STEP Award 8WB-0197 $378,972
Computer-Aided Discovery of Novel Breast Cancer Therapeutics 2000 (Cycle VI)
SPRC (Scientific Perspectives Research Collaboration) Exploratory Awards 6XB-0018 $112,041
Breast Cancer Chemoprevention by Vitamin D Plus Retinoids 1995 (Cycle I)
Research Project Awards 1RB-0120 $466,049
Breast Cancer Chemoprevention by Vitamin D Plus Retinoids 1995 (Cycle I)
Research Project Awards 1RB-0120A $0


Antagonist Analogue of 6-[3'-(1-Adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic Acid (AHPN) Family of Apoptosis Inducers That Effectively Blocks AHPN-Induced Apoptosis but Not Cell-Cycle. Arrest
  Periodical: Journal of Medicinal Chemistry
  Author(s): Dawson MI, Harris DL, et al.,and , Fontana JA
  Yr: 2004 Vol: 47 Nbr: 14 Pgs: 3518-3536
  Associated Grant: Novel Retinoids with Enhanced Anti-Breast Tumor Efficacy
 
Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
  Periodical: Blood
  Author(s): Zhang Y, Dawson MI, et al., and Fontana JA
  Yr: 2003 Vol: 102 Nbr: 10 Pgs: 3743-52
  Associated Grant: Novel Retinoids with Enhanced Anti-Breast Tumor Efficacy
 
Effect of trans-retinoic acid, 9-cis-retinoic acid, 1alpha,25-(dihydroxy)vitamin D3, and a novel apoptosis-inducing retinoid on breast cancer and endothelial cell growth
  Periodical: Cancer Letters
  Author(s): Dawson MI, Chao W, Hobbs PD, Zhang X, and Shroot B
  Yr: 1998 Vol: Nov 13 Nbr: 133 Pgs: 1-8
  Associated Grant: Breast Cancer Chemoprevention by Vitamin D Plus Retinoids